This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of atrophic vaginitis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • malignancy must be excluded

  • non-hormonal treatments
    • lubricants and moisturisers can be used in atrophic vaginitis
      • may be effective in treatment of dyspareunia in women with mild to moderate vaginal dryness
      • useful if contraindication to oestrogen/women does not want to use oestrogen

  • atrophic vaginitis may respond to a short course of vaginal oestrogen and may be required in addition to oral or transdermal HRT (see linked item). The usual dose is daily for two weeks and then twice weekly for up to three months
    • if only vaginal symptoms and no menopausal symptoms then vaginal oestrogen is often used (rather than systemic HRT)
    • approximately 10-25% of women receiving HRT will continue to have symptoms of atrophic vaginitis
      • these women may require topical oestrogen in addition to HRT

  • ospemifene is an alternative treatment for atrophic vaginitis

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.